PATENT CLAIM ANALYSIS

Application Number: 15768483
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "235800"]

Abstract:
Methods of the invention treat, reduce, or reverse fibrosis of a bodily tissue by administering to the local affected tissue a composition comprising an inhibitor of p38 MAP kinase, which treatment leads to a reduction or reversal of fibrosis.

Claim (Index 21):
The topical composition of  claim 20 , wherein the inhibitor is a small molecule, antibody, peptide, or nucleotide therapeutic.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 91.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15319254', '14718933', '13445759', '15083370', '14943752']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7124241109705981
- 35 USC 102 Novelty (BERT): 0.534939645146027
- Combined Prediction Score: 0.6946756643881411
- Mean Citation Score: 289.39753599999995
- Max Citation Score: 339.94452
- Similarity Product: 254.2392819540167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test